Torna ai risultati
Scheda bibliografica · Consultazione e accesso
Artículo

Markers of neuroinflammation in the CSF of patients with difficult to treat psychiatric disease

Jocelyn X. Jiang et al · Frontiers Media S.A · 2026

Accesso aperto disponibile
Lettura rapida. Controlla i dati essenziali della risorsa e accedi al contenuto con il pulsante principale. La scheda mostra solo le informazioni necessarie per identificare, citare e aprire l’opera.

Accesso alla risorsa

Apri il contenuto dall’opzione principale o scegli un’altra fonte disponibile.

DOAJ DOAJ Articles
Entrar por DOAJ
Accesso principale

Accesso aperto disponibile

Recurso identificado como acceso abierto, sin confirmar automáticamente si es texto completo directo.
Apri risorsa

Riepilogo

Descripción general del contenido del recurso.

IntroductionThe immune system is recognized as participating in the pathophysiology of psychiatric disease and there is renewed interest in identifying biomarkers of this immune activation. MethodsWe measured serum and cerebral spinal fluid (CSF) autoantibodies with other routine and novel markers of neuroinflammation, including CSF cytokines in patients with atypical psychiatric presentations of both psychotic and mood disorders (n=35). Their markers were compared with cohorts of non-inflammatory neurological disease (NIND) controls (n=18), patients with central nervous system (CNS) viral infection (n=22) and autoimmune encephalitis (AE; n=40). ResultsThe most common autoantibody detected in the serum of patients with psychiatric disease were anti-nuclear antibodies followed by thyroid autoantibodies. Few atypical psychiatric patients had abnormal conventional CSF markers of neuroinflammation (pleocytosis, oligoclonal bands, abnormal CSF IgG: albumin ratio). Further analysis of CSF revealed elevation of ITAC/CXCL11 in the psychiatric cohort. TARC/CCL17 was lower in the psychiatric cohort compared to other groups in a random-effects multinomial model, despite no significant differences on univariate analysis. When the values of CSF cytokines were examined in individual patients, six patients (17%) had at least one CSF cytokine greater than four standard deviations above the mean of the NIND cohort group. Extensive serological evaluation revised the diagnoses of six (17%) of our psychiatric group, and these patients’ showed improvement with immunosuppression. ConclusionOur results suggest a subset of people with atypical psychiatric disease may have a predominant immune contribution. This highlights the need for reevaluation and further consideration of differential diagnosis where patient presentations are not clinically typical, do not respond to conventional psychotropic treatment, or if other risk factors for autoimmunity are present.

Come citare

Elegí el formato que necesitás y copiá la referencia al portapapeles.

APA 7

al, J. X. J. E. (2026). Markers of neuroinflammation in the CSF of patients with difficult to treat psychiatric disease. https://doi.org/10.3389/fpsyt.2026.1665447

MLA

al, Jocelyn X. Jiang et. "Markers of neuroinflammation in the CSF of patients with difficult to treat psychiatric disease." 2026. https://doi.org/10.3389/fpsyt.2026.1665447.

Chicago

al, Jocelyn X. Jiang et. 2026. "Markers of neuroinflammation in the CSF of patients with difficult to treat psychiatric disease.". https://doi.org/10.3389/fpsyt.2026.1665447.

Harvard

al, J. X. J. E. 2026, Markers of neuroinflammation in the CSF of patients with difficult to treat psychiatric disease, Frontiers Media S.A, available at: https://doi.org/10.3389/fpsyt.2026.1665447 [Accessed 8 Aug. 2026].

Condividi e stampa

Salva la scheda, copia il link permanente o stampala in PDF.

Esporta riferimento

Esporta il record nei formati più comuni per usarlo con un gestore bibliografico.

Dettagli della risorsa

Informazioni bibliografiche utili per verificare che sia il materiale corretto.

Titolo
Markers of neuroinflammation in the CSF of patients with difficult to treat psychiatric disease
Autore / collaboratori
Jocelyn X. Jiang et al
Editore
Frontiers Media S.A
Anno di pubblicazione
2026
ISSN
1664-0640
ISSN
1664-0640
Lingua
Inglés

Soggetti

Esplora risorse correlate a partire da questi soggetti.

Copiato